New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction.
Miyata
T
T
Department of Internal Medicine, Branch Hospital, Nagoya University School of Medicine, Japan.
Maeda
K
K
D000686:Amyloidosis / Q000209:etiology*; D001847:Bone Diseases / Q000209:etiology*; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006801:Humans; D007592:Joint Diseases / Q000209:etiology*; D015416:Maillard Reaction; D006435:Renal Dialysis / Q000009:adverse effects*; D001613:beta 2-Microglobulin / Q000378:metabolism*
D017127:Glycation End Products, Advanced; D001613:beta 2-Microglobulin